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Abstract
Seasonal variation in serum concentration of the vitamin D metabolite 25(OH) vitamin D [25(OH)D], which contributes to
host immune function, has been hypothesized to be the underlying source of observed influenza seasonality in temperate
regions. The objective of this study was to determine whether observed 25(OH)D levels could be used to simulate observed
influenza infection rates. Data of mean and variance in 25(OH)D serum levels by month were obtained from the Health
Professionals Follow-up Study and used to parameterize an individual-based model of influenza transmission dynamics in
two regions of the United States. Simulations were compared with observed daily influenza excess mortality data. Best-
fitting simulations could reproduce the observed seasonal cycle of influenza; however, these best-fit simulations were
shown to be highly sensitive to stochastic processes within the model and were unable consistently to reproduce observed
seasonal patterns. In this respect the simulations with the vitamin D forced model were inferior to similar modeling efforts
using absolute humidity and the school calendar as seasonal forcing variables. These model results indicate it is unlikely that
seasonal variations in vitamin D levels principally determine the seasonality of influenza in temperate regions.
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Introduction
Hypotheses attempting to explain the seasonality of epidemic
influenza transmission in temperate regions fall into 3 broad
categories: 1) seasonal changes in host behavior, mixing patterns
and contact rates [1,2]; 2) seasonal changes in host immune
function [3,4]; and 3) seasonal changes of environmental
conditions that affect virus survival and transmissibility [5,6].
These 3 hypotheses are not mutually exclusive, and influenza
transmission dynamics are potentially affected in some fashion by
all 3 processes.
Here we explore the second effect, the role that seasonal
changes of host immune function may have on influenza infection
rates. In particular, we focus on the effect of vitamin D, which is
converted from 7-dehydrocholesterol in the skin upon absorption
of UVB rays from the sun [3]. The resulting product converts to
25-hydroxy-vitamin D3 [25(OH)D] and subsequently to 1,25-
dihydroxy-vitamin D3, which in combination with vitamin D
receptors triggers innate immune responses [7,8] that may be
effective against influenza infection [9,10], particularly at high
levels [11].
An association between vitamin D and likelihood of influenza
virus infection was first noted in laboratory experiments with
animal models [12]. A study on prevention of industrial
absenteeism also found that cod liver oil rich in vitamin D
reduced lost time due to respiratory illness [13]. Since those early
findings, a number of investigators have hypothesized that the
decreased sunlight levels in temperate regions during winter,
which decrease vitamin D concentrations and host immune
function, increase susceptibility to influenza infection [4,14].
Further, observational studies and a placebo-controlled trial also
found that higher levels of vitamin D or vitamin D supplemen-
tation prevented respiratory tract infections [15–17]. In this study
we explore whether seasonal vitamin D changes are by themselves
pronounced enough to modulate influenza infection rates.
Specifically, observed seasonal changes in vitamin D levels are
here used to modulate the probability of infection of individuals
within an agent-based model and determine whether a realistic
seasonal cycle of influenza infection rates can be simulated.
Methods
We compute monthly means and standard deviations of
25(OH)D levels in a sample of individuals enrolled in vitamin D
substudies in the Health Professionals Follow-up Study, a
prospective investigation of the causes of chronic diseases in male
health professionals [18]. We include 722 observations from
individuals residing in the Great Lakes region and 701
observations from those in the Northeast region whose blood
was drawn between the years 1993–1995 (Table 1).
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model previously described in Shaman et al. [6], but here adapted
for forcing with observed 25(OH)D levels, rather than absolute
humidity (AH). Briefly, the 25(OH)D level of each individual, or
agent, within the model is tracked explicitly. Each individual is
ranked and, based on this percentile, assigned a monthly 25(OH)D
level using the 1993–1995 average monthly mean and variance of
25(OH)D levels for the region modeled (e.g. the northeastern
U.S.); these average monthly 25(OH)D levels were approximately
normally distributed. To allow for additional daily variation
among individuals, each person was randomly allowed to drift
from their prescribed monthly 25(OH)D percentile by 60.1% per
day.
The 25(OH)D level, Vi,t, of individual i on day t was then
transformed into an adjustment of individual likelihood of
infection, ci,t, via (Figure 1):
ci,t~1{
ki,tz1
Q
ð1Þ
where ki,t is
ki,t~tanh
Vi,t{l
g

,
l determines the inflection point of the hyberbolic tangent
function, g modifies the slope through this inflection, and Q scales
ci,t to a value between 0 and 1. By defining the inflection point of
the hyperbolic tangent function, l sets the [25(OH)D] level at
which ci,t changes most precipitously (Figure 1). By modifying the
slope through the inflection point, g delineates whether the change
in ci,t as 25(OH)D level varies is gradual or more like a step
function.
The daily probability that a susceptible individual is infected, ni,t
is then scaled by this adjustment:
ni,t~ci,t
bIt
N
ð2Þ
where b is the transmission rate constant, It is the daily number of
infectious people, and N is the population size. By construct,
persons with higher 25(OH)D levels have smaller ci,t and reduced
risk of infection. For the population as a whole, the daily mean
value of ci,t modifies the basic reproduction number, R0, such that
an instantaneous basic reproduction number for the population
can be defined as R0t~E ct ½  R0. R0trepresents the number of
secondary cases a primary case would infect if no one were
immune and the distribution of ci,t were that observed on day t.
This instantaneous basic reproduction number accounts for
changes in the likelihood of infection due to population mean
Vitamin D levels; however, this quantity does not account for
susceptibility to influenza, i.e. immune status. The actual mean
number of secondary cases per case at a given time is the effective
reproductive number, which is approximatelyREt&R0t
St
N
and
determines whether total cases are increasing or declining in the
population. This relation is approximate because it does not take
account of the possible correlation between an individual’s vitamin
D status and whether or not s/he is in the immune category. The
model accounts for such correlations by modeling transmission
(and vitamin D status) at the individual level.
The model includes 6 free parameters and was run in ensembles
of 3000 simulations. Parameters l and g were fixed for all 3000
runs of an ensemble, but varied between ensembles. The
remaining 4 parameters—Q, R0
*, the value R0 would have if ci,t
equaled one for the entire population, D, the mean infectious
period, and L, the average duration of immunity—were varied
among the simulations within an ensemble using a Latin
hypercube sampling structure with uniform distribution, as in
Shaman et al. [6]. Parameter ranges were: l~½20,25 ng=ml;
g~½2,10 ng=ml; Q~½2{10 ; R0
 ~ 0:8,4:0 ½  ; D~½2,7 days;
L~½2{10 years. The range of l was assigned to match levels
below which parathyroid hormone levels are elevated [3,19]; the
Table 1. 1993–1995 average monthly mean and standard deviation of 25-hydroxy-vitamin D levels for the Great Lakes and
Northeast U.S. regions.
Great Lakes Northeast
Month Number Mean Standard Deviation Number Mean Standard Deviation
January 25 24.28 8.39 16 25.44 7.52
February 24 23.05 6.92 23 26.83 9.01
March 47 25.04 9.49 35 23.77 10.32
April 31 24.81 6.35 25 23.59 11.78
May 49 26.60 7.67 57 26.79 9.69
June 94 28.57 8.45 105 27.99 13.85
July 78 32.46 11.34 96 29.51 9.17
August 73 32.14 9.52 85 31.52 9.47
September 156 32.13 10.74 98 31.63 12.62
October 68 28.82 10.70 68 28.65 9.83
November 46 27.94 9.13 60 25.89 9.87
December 31 26.71 8.34 33 24.26 7.53
The Great Lakes includes the states of Illinois, Indiana, Iowa, Michigan, Minnesota, Montana, and Wisconsin. The Northeast includes the states of Connecticut, Delaware,
Maine, Maryland, Massachusetts, New Hampshire, New Jersey, New York, Pennsylvania, Rhode Island, West Virginia, Vermont and the District of Columbia.
doi:10.1371/journal.pone.0020743.t001
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*, D, and, L match those employed previously for this
model [6]; g and Q were varied to consider a wide range of
potential responses to higher 25(OH)D levels. R0
* was allowed to
drop below critical levels for some simulations, though these few
runs fail to sustain continued influenza transmission; more often
R0
* was prescribed to be above 2, though daily modulation of R0
*
by ci,t typically produced instantaneous basic reproduction
numbers (R0t) of much lower magnitude within such simulations.
Each simulation used a population of N=100,000 persons and
was run for 31 years. The model simulates two influenza virus
groupings (A-H3N2 and a grouping of the A-H1N1 and B
subtypes) without cross immunity. The quality of each simulation
was evaluated based on root mean squared (RMS) error with daily
observed 1972–2002 excess pneumonia and influenza (P&I)
mortality [20,21]. Simulations for the northeast U.S. region were
evaluated with New York state excess P&I mortality. Simulations
for the Great Lakes region were evaluated with Illinois state excess
P&I mortality.
To test the sensitivity of model outcome to stochastic processes
we re-ran the 10 best-fitting parameter combinations for certain
ensembles. Each of these parameter combinations was run 100
additional times, each time with different random seeding, to
examine the role stochasticity had in producing well-matched
simulations. An analogous test was performed in Shaman et al. [6]
for simulations forced with either AH or the school calendar.
Additionally, to determine whether the vitamin D-forced
simulations were corrupted by the coarse monthly temporal
resolution of the data, we interpolated the mean and variance of
the monthly vitamin D data to daily values using a cubic spline
and used these daily-interpolated values to force the influenza
model. Simulations were repeated in this fashion for both the
Northeast and Great Lakes regions, and the role of stochasticity
was also examined, as described above. For these daily
interpolated runs individuals were still ranked but were instead
assigned a daily 25(OH)D level based on the daily mean and
variance.
Figure 1. ki,t and ci,t plotted as a function of 25(OH)D level for
various parameter combinations. a) ki,t plotted for different
combinations of l and g.b )ci,t plotted for l=20ng/ml and
g=10ng/ml and different levels of Q.c )ci,t plotted for l=20ng/ml
and g=2ng/ml and different levels of Q.
doi:10.1371/journal.pone.0020743.g001
Table 2. Parameter combinations for the 10 best-fit
simulations for the Great Lakes region as validated with Illinois
P&I mortality data.
Rank RMS Error
Correlation
Coefficient (r)
L
(years)
D
(days) Q R0
*
1 0.0049 0.93 5.74 4.58 5.11 2.35
2 0.0061 0.87 3.81 2.08 3.33 2.84
3 0.0062 0.84 9.78 2.68 4.92 1.90
4 0.0062 0.86 3.54 3.60 2.85 3.18
5 0.0064 0.86 3.66 3.29 3.67 2.29
6 0.0064 0.88 4.39 6.47 7.13 2.69
7 0.0065 0.83 7.65 2.42 2.79 3.69
8 0.0066 0.82 4.59 2.71 3.30 2.34
9 0.0069 0.82 4.81 6.53 3.15 3.32
10 0.0069 0.91 7.41 5.80 7.71 2.14
3000 simulations were performed at each site with the parameters L (mean
duration of immunity), D (mean infectious period), Q (vitamin D scaling), and
R0
* (the basic reproduction number if ci,t=1) randomly chosen from within
specified ranges. Parameters l (inflection point) and g (inflection point slope)
were fixed at l~20ng=ml and g~10ng=ml. Best-fit simulations were selected
based on RMS error after scaling the 31-year mean daily infection number to
the 31-year mean observed daily excess P&I mortality rate.
doi:10.1371/journal.pone.0020743.t002
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simulations forced with either AH or the school calendar for New
York state and Illinois; the descriptions and parameterizations of
these models can be found in Shaman et al. [6]. In addition, new
AH-forced simulations were run for both New York state and
Illinois in which the 1972–2002 time series of daily AH conditions
for each of these states was replaced with 31-year daily average
values. This averaging eliminates year-to-year variability from the
AH-forcing and provides a more fair comparison with the vitamin
D- and school calendar-forced model runs, which also lack year-
to-year variability.
Results
Best-fitting simulations are presented for the Great Lakes
region using l~20ng=ml and g~10ng=ml (Table 2) and the
northeast U.S. using l~25ng=ml and g~4ng=ml (Table 3).
Results with other combinations of l and g, as well as with
forcing using daily interpolated 25(OH)D levels were compara-
ble (not shown). The quality of these simulations in terms of
RMS error and correlation with observed P&I mortality is
comparable to simulations with the AH and school calendar
forced SIRS model (see Tables S2 and S5 in Shaman et al. [6]).
Simulated daily average infection rates capture the seasonal
cycle of P&I mortality (Figure 2).
Only a portion of the population seasonally crosses the
inflection point for ci,t as 25(OH)D levels change (Figure 1b,c)
such that only a portion of the population experiences a
pronounced modulation of the likelihood of infection. When
the slope of ki,t at its inflection is steep (i.e. g small) large
p o r t i o n so ft h ep o p u l a t i o ne x p e r i e n c el i t t l es e a s o n a lc h a n g ei n
ci,t. Still, the portion that is modulated is sufficient at times to
phase peak infection during winter and produce a realistic
seasonal cycle.
However, best-fitting model parameter combinations are not
consistent among best-fitting runs (Tables 2 and 3), unlike what
has been found for simulations forced with observed absolute
humidity. Furthermore, some simulations with similar parameter
combinations produce anti-correlated seasonal cycles of influenza
infection (r~{0:69). These findings indicate that the quality of fit
might be heavily influenced by stochastic events, such that
particular parameter combinations could on occasion produce a
realistic seasonal cycle, but would not reliably do so. To test this
hypothesis, we re-ran the simulations with the top 10 parameter
combinations as described in the Methods section. An identical
test had previously been performed for SIRS simulations forced
with either AH or the school calendar [6] and both these alternate
forcing mechanisms prove more resilient to changes in random
seeding with AH performing the best (Figure 3).
As a reference, a simple sine function with annual period, if
appropriately phased, is highly correlated with the seasonal cycle
Table 3. Parameter combinations for the 10 best-fit
simulations for the northeastern U.S. as validated with New
York state P&I mortality data.
Rank RMS Error
Correlation
Coefficient
(r)
L
(years)
D
(days) Q R0
*
1 0.0070 0.94 5.59 5.69 3.83 2.83
2 0.0071 0.94 5.64 5.43 4.99 2.48
3 0.0071 0.90 9.78 5.59 2.43 3.69
4 0.0072 0.88 9.80 3.59 2.55 3.83
5 0.0072 0.90 2.53 6.04 2.86 2.44
6 0.0073 0.89 9.71 3.68 5.54 1.94
7 0.0074 0.89 3.28 4.31 2.13 3.22
8 0.0075 0.90 8.73 3.74 6.79 3.02
9 0.0077 0.91 6.44 5.72 4.24 2.59
10 0.0077 0.91 6.29 3.17 9.27 1.74
3000 simulations were performed at each site with the parameters L (mean
duration of immunity), D (mean infectious period), Q (vitamin D scaling), and
R0
* (the basic reproduction number number if ci,t=1) randomly chosen from
within specified ranges. Parameters l (inflection point) and g (inflection point
slope) were fixed at l~25ng=ml and g~4ng=ml. Best-fit simulations were
selected based on RMS error after scaling the 31-year mean daily infection
number to the 31-year mean observed daily excess P&I mortality rate.
doi:10.1371/journal.pone.0020743.t003
Figure 2. Best-fitting SIRS model simulation for the northeastern U.S. with parameters l and g fixed at l~25ng=ml and g~4ng=ml.
Other parameters are shown in the top line of Table 3. The 31-year simulated mean daily infection number has been scaled to the observed 1972–
2002 mean daily excess P&I mortality rate for New York state.
doi:10.1371/journal.pone.0020743.g002
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state, Figure 3). One might expect that a credible process-based
model of the seasonal influenza cycle would consistently improve
on this correlation. However, in comparison to school-term
forcing and AH forcing, the re-run top parameter sets for
25(OH)D forcing performed considerably worse, as measured by
the Pearson correlation between re-run simulations and observa-
tions. Specifically, the additional AH forced simulations are much
more consistently matched with observations (mean r=0.912;
minimum r=0.670; maximum r=0.981) than the additional
school calendar forced simulations (mean r=0.704; minimum
r=20.024; maximum r=0.962) or the additional vitamin D
forced simulations (mean r=0.490; minimum r = 20.512;
maximum r=0.950) (Figure 3a). Both the school and vitamin D
Figure 3. Test of the effect of stochasticity within the SIRS model on well-matched simulations verified with New York state P&I
mortality data. a) The 10 best-fit parameter combinations for the SIRS model forced with observed New York school calendar (Shaman et al., 2010:
Table S5), observed New York absolute humidity (Shaman et al., 2010: Table S2), and northeastern U.S. vitamin D metabolite levels (Table 3) were
each run an additional 100 times, each time with different random seeding. Histograms of correlations with 1972–2002 New York state observed
excess P&I mortality are shown. The green line indicates the correlation of an optimally phased sine function with annual periodicity with 1972–2002
New York state observed excess P&I mortality (r=0.80). b) As in a), but for the 10 best-fit simulations using 1972–2002 daily average New York
absolute humidity and daily interpolated northeastern U.S. vitamin D metabolite levels.
doi:10.1371/journal.pone.0020743.g003
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sine function model.
A similar test of the effect of stochasticity for the model forced
with daily-interpolated vitamin D levels was also not consistently
well matched with observations (mean r=0.516; minimum r =
20.550; maximum r=0.965) (Figure 3b). Conversely, the same
test applied to daily-averaged AH-forced simulations was consis-
tently well matched with observations (mean r=0.904; minimum
r=0.558; maximum r=0.984). These last two ensembles both use
daily forcing without any year-to-year variability, yet the AH-
forced model is much more consistently highly correlated with
observations than the vitamin D model and on average is better
correlated than the naı ¨ve sine function model.
Discussion
Simulation of the seasonal cycle of influenza infection in regions
of the U.S. is possible using an SIRS model forced with observed
vitamin D levels. However, secondary evidence casts doubt on the
validity of this outcome. Parameter combinations that produce a
good seasonal cycle of influenza are not similar to one another,
and multiple stochastic runs do not reproduce the seasonal cycle
reliably, in contrast to similar runs with the other candidate drivers
of seasonality, in particular AH.
Any forcing with a strong seasonal cycle will produce an
appropriate seasonal cycle of influenza infection when applied to
an SIRS model with an appropriate combination of parameters
and stochastic events. For such results to be credible, however, it is
necessary that the parameter combinations that produce best-
fitting simulations are biologically plausible, approximately
consistent from one simulation to another, and are not easily
affected by random events within the model. The model presented
here fails the latter 2 conditions and therefore suggests that
seasonal changes in vitamin D levels are not the predominant
determinant of influenza seasonality in temperate regions.
The generalizability of our study may be limited by the fact that
vitamin D levels were measured only in male health professionals;
nonetheless, the mean 25(OH)D values were similar to those of a
nationally representative study population [22]. Within the Health
Professionals vitamin D dataset used here [18], no age-related
differences in seasonal vitamin D levels were evident. In the future,
should more detailed data representing a broader demography
become available in which age-stratified vitamin D effects are
evident, these effects could be incorporated and tested within the
model framework.
Given that vitamin D affects the immune system [7,8], one can
hypothesize that severity and duration of influenza infection would
also be modulated by vitamin D levels; however, we are unaware
of any observational evidence supporting this hypothesis. Should
such findings emerge in the future, this evidence would motivate
proper testing of vitamin D-induced changes in the severity or
duration of infection on the seasonality of influenza. This study
was also limited by a lack of detailed daily 25(OH)D data; however,
25(OH)D levels are not subject to drastic day-to-day variations so
this shortcoming likely did not affect our results.
Previous work indicates that increased solar radiation anomalies
are associated with the onset of individual influenza outbreaks [6].
This association between increased sunlight availability and
increased influenza transmission is incongruous with the vitamin
D hypothesis (i.e. of the wrong sign) and also undermines the
notion that vitamin D is a dominant driver of influenza
transmission in temperate regions. While it remains possible that
low levels of vitamin D could contribute to influenza occurrence,
we conclude that present evidence for seasonal variation in serum
vitamin D metabolite levels as a driver for influenza seasonality is
considerably weaker than that for other proposed mechanisms, in
particular seasonal variation in AH and seasonal changes in host
aggregation driven by school terms.
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